The Centre for Genomic Regulation (CRG) (Barcelona, Spain) and the Fundació ACE - Barcelona Alzheimer Treatment & Research Centre (Barcelona, Spain) have signed an agreement to collaborate on scientific projects related to neurodegenerative diseases.
The Centre for Genomic Regulation (CRG) (Barcelona, Spain) and the Fundació ACE - Barcelona Alzheimer Treatment & Research Centre (Barcelona, Spain) have signed an agreement to collaborate on scientific projects related to neurodegenerative diseases.
The agreement, which will initially last for two years, aims to encourage collaboration between the centres. They will work together in the area of genomics as well as functional studies of cases of neurodegenerative diseases.
Dr Mercè Boada, medical director of the ACE Foundation, said, “The start of this collaboration with the CRG represents a huge step forward for our institution and strengthens the basic research of the ACE Foundation. The agreement will allow us to intensify our research on the genetic causes of dementia and complements the collaborations that have been initiated with the international metaconsortia CHARGE and IGAP.”
Xavier Estivill, coordinator of the CRG Genes and Disease programme, commented, “If we study neurodegenerative diseases from a genomic perspective we will probably discover fundamental explanations about the causes. As we age later in life than we did previously, neurodegenerative diseases are becoming more common. Understanding the biological basis of these ailments will help us to delay their appearance, improve diagnosis, and develop new treatments.”
For more information please visit ref="http://www.crg.es">www.crg.es
Sustainable Green Solvents in Microextraction: A Review of Recent Advancements
March 27th 2024Conventional sample preparation can be time- and resource-consuming, and a green analytical methodology can be a game-changer for scientists, in addition to facilitating selective and sensitive separations.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.
High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS (Apr 2024)
March 27th 2024This study demonstrates high-throughput analysis of BTEX compounds from several matrices (air, water and soil). Detection limits in the single-digit part-per-billion concentration range (by volume) are readily achievable within seconds using SIFT-MS, because sample analysis is achieved without chromatography, pre-concentration, or drying. We also present a calibration approach that enables speciation of ethylbenzene from the xylenes in real time.